Aarkstore.com || Hereditary Angioedema (HAE) – Pipeline Review, H1 2012 || Market Research

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Hereditary Angioedema (HAE) – Pipeline Review, H1
2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Hereditary Angioedema (HAE) - Pipeline Review, H1 2012,
provides an overview of the Hereditary Angioedema (HAE) therapeutic pipeline.
This report provides information on the therapeutic development for Hereditary
Angioedema (HAE), complete with latest updates, and special features on late-stage
and discontinued projects. It also reviews key players involved in the therapeutic
development for Hereditary Angioedema (HAE). Hereditary Angioedema (HAE) -
Pipeline Review, H1 2012 is built using data and information sourced from Global
Markets Direct’s proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from company/university sites
and industry-specific third party sources, put together by Global Markets Direct’s
team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Hereditary Angioedema (HAE).
- A review of the Hereditary Angioedema (HAE) products under development by
companies and universities/research institutes based on information derived from

2. company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Hereditary Angioedema (HAE) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Hereditary Angioedema (HAE) 7
Hereditary Angioedema (HAE) Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Pre-Clinical Stage Products 12
Comparative Analysis 12
Hereditary Angioedema (HAE) Therapeutics – Products under Development by
Companies 13
Companies Involved in Hereditary Angioedema (HAE) Therapeutics Development
14
Pharming Group N.V. 14
Dyax Corp. 15
ViroPharma Incorporated 16
Shire Plc 17
BioCryst Pharmaceuticals, Inc. 18
Hereditary Angioedema (HAE) – Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Combination Products 20
Assessment by Route of Administration 21
Assessment by Molecule Type 23

3. Drug Profiles 25
RhC1INH - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Rhucin - Drug Profile 26
Product Description 26
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1
2012&PubId=&pagenum=1
Hereditary Angioedema (HAE) – Pipeline Review, H1 2012
Cataract – Pipeline Review, H1 2012
Neurofibromatoses – Pipeline Review, H1 2012
Viral Conjunctivitis – Pipeline Review, H1 2012
Fistula – Pipeline Review, H1 2012

4. Onchocerciasis (River Blindness) – Pipeline Review, H1 2012
Seborrhea – Pipeline Review, H1 2012
Cerebral Palsy – Pipeline Review, H1 2012
Hemolytic Disease In Newborns – Pipeline Review, H1 2012
Panic Disorders – Pipeline Review, H1 2012
4SC AG – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com